Thin-Layer-Agar-Based Direct Phenotypic Drug Susceptibility Testing on Sputum in Eswatini Rapidly Detects Mycobacterium tuberculosis Growth and Rifampicin Resistance Otherwise Missed by WHO-Endorsed Diagnostic Tests.

Xpert MTB/RIF rapidly detects resistance to rifampicin (RR); however, this test misses I491F-RR conferring rpoB mutation, common in southern Africa. In addition, Xpert MTB/RIF does not distinguish between viable and dead Mycobacterium tuberculosis (MTB). We aimed to investigate the ability of thin-layer agar (TLA) direct drug-susceptibility testing (DST) to detect MTB and its drug-resistance profiles in field conditions in Eswatini. Consecutive samples were tested in parallel with Xpert MTB/RIF and TLA for rifampicin (1.0 µg/ml) and ofloxacin (2.0 µg/ml). TLA results were compared at the Reference Laboratory in Antwerp with indirect-DST on Löwenstein-Jensen or 7H11 solid media and additional phenotypic and genotypic testing to resolve discordance. TLA showed a positivity rate for MTB detection of 7.1% versus 10.0% for Xpert MTB/RIF. Of a total of 4,547 samples included in the study, 200 isolates were available for comparison to the composite reference. Within a median of 18.4 days, TLA detected RR with 93.0% sensitivity (95% confidence interval [CI], 77.4 to 98.0) and 99.4% specificity (95% CI, 96.7 to 99.9) versus 62.5% (95% CI, 42.7 to 78.8) and 99.3% (95% CI, 96.2 to 99.9) for Xpert MTB/RIF. Eight isolates, 28.6% of all RR-confirmed isolates, carried the I491F mutation, all detected by TLA. TLA also correctly identified 183 of the 184 ofloxacin-susceptible isolates (99.5% specificity; 95% CI, 97.0 to 99.9). In field conditions, TLA rapidly detects RR, and in this specific setting, it contributed to detection of additional RR patients over Xpert MTB/RIF, mainly but not exclusively due to I491F. TLA also accurately excluded fluoroquinolone resistance.

Kounis syndrome after levofloxacin intake: a clinical report and cross-reactivity study

No disponible

Ondansetron hypersensitivity: a clinical diagnosis protocol and cross-reactivity study

No disponible

Interleukin 1 gene cluster SNPs (rs1800587, rs1143634) influences post-orthodontic root resorption in endodontic and their contralateral vital control teeth differently.

AIM: To investigate whether the genetic variants of the interleukin-1 gene cluster (IL1) are associated with a possible genetically induced variability in post-orthodontic external apical root resorption (EARR) in root filled teeth and their control counterparts with vital pulps. METHODOLOGY: One hundred and forty-six maxillary premolars were evaluated radiographically following orthodontic treatment. Genetic screening was performed on orthodontic patients for two single-nucleotide polymorphisms (SNPs: rs1800587 and rs1143634) in the IL1 gene cluster. Subjects were divided into two groups according to the presence or absence of radiographic post-orthodontic EARR (>2 mm) in root filled teeth and their controls with vital pulps. Logistic regression analysis was performed to obtain an adjusted estimation between EARR and IL1 polymorphisms. Allelic frequencies, genotype distributions, and adjusted odds ratio (OR), at 95% confidence interval, were also calculated. RESULTS: Whilst no clear statistical association was found for gene variations in IL1A, a sound association was found in the comparative analysis of subjects homozygous [2/2(TT)] for the IL1B gene, which resulted in a two times increased risk of suffering post-orthodontic EARR in root filled teeth [OR, 2.032 (P = 0.031); CI,1.99-14.77] when compared with their controls with vital pulps. There was, however, a shared predisposition to EARR in controls with vital pulps and root filled teeth of subjects homozygous for allele 1 [OR, 5.05 (P = 0.002)] and [OR, 2.77 (P = 0.037)], respectively. CONCLUSIONS: Genetic variations in the interleukin-1ß gene (rs1143634) predispose root filled teeth to EARR for matched pairs secondary to orthodontic treatment in a different way from their control teeth with vital pulps in subjects homozygous for allele 2 [2/2(TT)].

Postorthodontic external root resorption is associated with IL1 receptor antagonist gene variations.

OBJECTIVE: External apical root resorption (EARR) is a frequent iatrogenic effect of orthodontic treatment. Patients with genetic variants in the interleukin 1 gene have been related to an increased risk of suffering EARR. The objective of this study is to determine whether variants in the interleukin 1 receptor antagonist gene are positively/negatively associated with interleukin 1 gene polymorphisms, particularly in relation to the clinical features of EARR patients. MATERIALS AND METHODS: Genetic screening of 54 orthodontic patients was performed for three polymorphisms (rs1800587, rs1143634 and rs419598) in the IL1 gene cluster. Subjects were divided according to the presence or absence of EARR of more than 2 mm. The genotype distributions and allelic frequencies were calculated by the chi-square-test. Odds ratios (OR) and 95% confidence intervals were also calculated. RESULTS: A highly significant association was found in the comparative analysis of homozygous subjects [1/1(CC)] for the IL1B gene, resulting in an increased risk of suffering postorthodontic EARR (OR: 3.47; P = 0.027; CI: 95%). While no association was found for the IL1A gene (P = 0.097), subjects who were homozygous [1/1(TT)] for the IL1RN gene were more likely to be affected with EARR (OR: 6.75; P = 0.001; CI: 95%). CONCLUSION: Variations in the interleukin 1 receptor antagonist gene (rs419598) - and not only in the IL1B gene (rs1800587) - are determinants of a predisposition to postorthodontic EARR.

Tolerancia al material de osteosíntesis en cirugía electiva del maxilar superior / Tolerance of the ostheosynthesis material in elective surgery of the superior maxilla

Se evaluaron retrospectivamente un total de 36 pacientes sometidos a osteotomía de LeFort I. En 21 de estos pacientes (8 hombres y 13 mujeres con edad media 20,8 años) se realizaron osteotomías estándar con corrección del defecto con miniplacas en forma de "L", usando en 11 casos miniplacas 2,0 y el resto 1,5. Se sometieron a los 15 pacientes restantes (8 hombres y 7 mujeres con edad media 39,6 años) a osteotomía segmentada sagital para el abordaje lesiones de la base del cráneo, colocando en todos ellos miniplacas de 2,0. Después de un seguimiento mínimo de 30 meses se llegaron a los siguientes resultados: De un total de 160 miniplacas colocadas ( 84 en grupo estándar y 76 en osteotomías de abordaje neuroquirurgico) se retiraron sólo 4 de estas miniplacas, 2 de ellas por palpación intraoral y 2 por exposición. Por todo lo expuesto y en comparación con otras series concluimos que la baja incidencia de complicaciones derivadas del material de osteosíntesis no justifica su retirada sistemática en las osteotomías de maxilar superior. (AU)